SC Filed 2021-09-16 Event — SEC 0001567619-21-017202 →

BAUPOST GROUP LLC/MA → Translate Bio, Inc.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

19 filings by this filer

18 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Translate Bio, Inc.

Filed	Form	Filer	Stake	Shares
2021-08-04	SC	BAUPOST GROUP LLC/MA	—	—	view →
2020-08-10	SC	BAUPOST GROUP LLC/MA	—	—	view →
2020-05-11	SC	BAUPOST GROUP LLC/MA	—	—	view →

Other Filings by BAUPOST GROUP LLC/MA

Filed	Form	Issuer	Stake	Shares
2023-07-27	SC	Garrett Motion Inc. GTX	—	—	view →
2023-07-17	SC	Garrett Motion Inc. GTX	—	—	view →
2021-12-14	SC	Garrett Motion Inc. GTX	—	—	view →
2021-11-10	SC	VIASAT INC VSAT	—	—	view →
2021-08-04	SC	Translate Bio, Inc.	—	—	view →
2021-05-05	SC	VIASAT INC VSAT	—	—	view →
2021-05-04	SC	Garrett Motion Inc. GTX	—	—	view →
2021-03-10	SC	Garrett Motion Inc. GTX	—	—	view →
2021-01-26	SC	Garrett Motion Inc. GTX	—	—	view →
2021-01-13	SC	Garrett Motion Inc. GTX	—	—	view →
2020-11-17	SC	Garrett Motion Inc. GTX	—	—	view →
2020-11-04	SC	Garrett Motion Inc. GTX	—	—	view →
2020-08-10	SC	Translate Bio, Inc.	—	—	view →
2020-07-27	SC	VIASAT INC VSAT	—	—	view →
2020-05-11	SC	Translate Bio, Inc.	—	—	view →
2019-06-04	SC	Orexigen Therapeutics, Inc.	—	—	view →
2018-05-10	SC	KERYX BIOPHARMACEUTICALS INC	—	—	view →
2018-04-26	SC	Orexigen Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →